Details

Karakterizacija Cr-Mo-W-V orodnega jekla : diplomsko delo
ID Kosovinc, Tilen (Author), ID Naglič, Iztok (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (2,98 MB)
MD5: 83656E77F629132D9F33996CF2257195
PID: 20.500.12556/rul/796525aa-c932-4173-a264-b3da15efbb10

Language:Slovenian
Keywords:orodno jeklo, karakterizacija, mikrostruktura, karbidi
Work type:Bachelor thesis/paper
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[T. Kosovinc]
Year:2016
Number of pages:37 f.
PID:20.500.12556/RUL-87829 This link opens in a new window
UDC:669.2/.8
COBISS.SI-ID:1613919 This link opens in a new window
Publication date in RUL:16.12.2016
Views:18323
Downloads:501
Metadata:XML DC-XML DC-RDF
:
KOSOVINC, Tilen, 2016, Karakterizacija Cr-Mo-W-V orodnega jekla : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : T. Kosovinc. [Accessed 30 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=87829
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:tool steel, characterization, microstructure, carbides

Similar documents

Similar works from RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back